Epitope spreading as an early pathogenic event in pediatric multiple sclerosis
暂无分享,去创建一个
D. Arnold | H. Weiner | A. Bar-Or | B. Banwell | F. Quintana | S. Narayanan | Julia O'mahony | S. Magalhaes | Jessica E. Kenison | Dumitru Fetco | S. Rajasekharan | M. Nyirenda | A. Yeste | B. Patel | Roya Rahbari | M. Hussain | Melissa McGowan | T. Johnson | Julia O’Mahony | Trina A. Johnson
[1] F. Paul,et al. T-cell homeostasis in pediatric multiple sclerosis , 2013, Neurology.
[2] Francisco J. Quintana,et al. Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis , 2012, Proceedings of the National Academy of Sciences.
[3] A. Bar-Or,et al. Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis , 2012, Annals of neurology.
[4] I. Cohen,et al. Antigen microarrays identify CNS-produced autoantibodies in RRMS , 2012, Neurology.
[5] D. Arnold,et al. MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study , 2011, The Lancet Neurology.
[6] A. Bar-Or,et al. Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis , 2011, Neurology.
[7] Daniela Pohl,et al. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study , 2011, The Lancet Neurology.
[8] H. Weiner,et al. An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis , 2010, Proceedings of the National Academy of Sciences.
[9] Jing Cui,et al. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score , 2009, The Lancet Neurology.
[10] Guillermo Izquierdo,et al. Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis , 2008, Proceedings of the National Academy of Sciences.
[11] E. Radue,et al. Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis , 2008, Annals of neurology.
[12] A. Bar-Or,et al. Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions , 2007, The Lancet Neurology.
[13] D. Arnold,et al. Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial. , 2007, Archives of neurology.
[14] S. Miller,et al. CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ TH-17 cells in relapsing EAE , 2007, Nature Immunology.
[15] G. Meiffren,et al. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. , 2006, The Journal of clinical investigation.
[16] K. Venken,et al. Secondary progressive in contrast to relapsing‐remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T‐cell function and FOXP3 expression , 2006, Journal of neuroscience research.
[17] W. Robinson,et al. Lipid microarrays identify key mediators of autoimmune brain inflammation , 2006, Nature Medicine.
[18] S. Reingold,et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.
[19] S. Miller,et al. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis , 2005, Nature Medicine.
[20] Eytan Domany,et al. Functional immunomics: Microarray analysis of IgG autoantibody repertoires predicts the future response of mice to induced diabetes , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[21] Clare Baecher-Allan,et al. Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis , 2004, The Journal of experimental medicine.
[22] Lawrence Steinman,et al. Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis , 2003, Nature Biotechnology.
[23] P. Brown,et al. Autoantigen microarrays for multiplex characterization of autoantibody responses , 2002, Nature Medicine.
[24] S. Miller,et al. Epitope spreading in immune-mediated diseases: implications for immunotherapy , 2002, Nature Reviews Immunology.
[25] C. Poser,et al. Diagnostic criteria for multiple sclerosis , 2001, Clinical Neurology and Neurosurgery.
[26] R. Hohlfeld,et al. Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects: epitope spreading versus clonal persistence. , 2000, Brain : a journal of neurology.
[27] E. Sercarz,et al. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen , 1992, Nature.